Hospital discharge policy in thyroid cancer patients treated with 131I: The effect of changing from fixed time to exposure rate threshold

Health Physics

Volumn 72, Issue 3, 1997, Pages 476-480

  Mohammadi, Hooshang ^b   Saghari, Mohsen ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b NONE

Author keywords

131I; cancer; radiation, medical; thyroid

Indexed keywords

IODINE 131;

ARTICLE; CANCER RADIOTHERAPY; HOSPITAL DISCHARGE; IRAN; METASTASIS; POLICY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; THYROID CANCER;

EID: 0031024319     PISSN: 00179078     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004032-199703000-00017     Document Type: Article

References (17)

1. Beierwaltes, W. H.; Nishyama, R. H.; Thomas, N. W. Survival time and "cure" in papillary and follicular thyroid carcinoma with distant metastases: Statistics following University of Michigan therapy. J. Nucl. Med. 23:561-568; 1982.
2. 131I in 511 patients from 1974-1984:Experience at University of Michigan. J. Nucl. Med. 25:1287-1293; 1984.
3. Culver, C. M.; Dowrkin, H. J. Radiation safety consideration for post-iodine-131 for thyroid cancer therapy. J. Nucl. Med. 33:1402-1405; 1992.
4. DeGrout, L. J.; Reilly, M. Comparison of 430- and 50-mCi doses of iodine-131 for thyroid ablation. Ann. Intern. Med. 96:51-53; 1982.
5. Hurley, J. R.; Decker, D. V. The use of radioiodine in the management of thyroid cancer. In: Freeman, L. M.; Weissman, H. S., eds. Nuclear Medicine Annal. New York: Raven Press; 1983: 329.
6. International Commission on Radiological Protection. Protection of the patients in nuclear medicine. ICRP publication 52. Oxford: Pergamon Press; 1987.
7. Koga, S.; Nishizawa, K. A proposal of radioactivity levels for discharge of radioactive patients from hospital based on the data of external exposure. Radioisotopes 23:37; 1974.
8. Mazzaferri, E. L.; Young, R. L. Papillary thyroid carcinoma: A 10 year follow up report of therapy in 576 patients. Am. J. Med. 70:511-518; 1981.
9. McCowen, K. D.; Adler, A.; Ghaed, N; Verdon, T.; Hofeldt, F. D. Low dose radioiodide thyroid ablation in post surgical patients with thyroid cancer. Am. J. Med. 61:52-58; 1976.
10. McKenzie, A. L.; Shaw, J. E.; Stephenson, S. K.; Turner, R. C. R. Radiation protection in Radiotherapy. York, UK: The Institute of Physical Sciences in Medicine; 1986.
11. National Council on Radiation Protection and Measurements. Precautions in management of patients who have received therapeutic amounts of radionuclides. Washington, DC: NCRP; Report 37; 1970.
12. National Radiological Protection Board. Guidance notes for the protection of persons against ionizing radiations arising from medical and dental use. London: Her Majesty's Stationery Office; 1986.
13. Nishizawa, K.; Ohara, K.; Oshima, M.; Maekoshi, H.; Onto, T.; Watanabe, T. Monitoring of I excretions and used materials of patients treated with I. Health Phys. 38:467-481; 1980.
14. Ramacciotli, C.; Pretorius, H.; Line, B. R. Goldman, J. M.; Robbins, J. Ablation of nonmalignant thyroid remnants with low doses of radioactive iodine. J. Nucl. Med. 23:483-489; 1982.
15. 131I to ablate normal thyroid tissue in patients from whom thyroid cancer has been resected. J. Nucl. Med. 24:743-745; 1983.
16. 131I therapy for thyroid cancer. Radiology 137:839-842; 1980.
17. Tubiana, M. Thyroid cancer. In: Deckers, C. Thyroid diseases. France: Pergamon Press; 1982: 187-227.